Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone
about
Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP betaArthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone lossInflammatory related changes in bone mineral content in adults with cystic fibrosisRoles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells.IL-1-induced murine osteoblast IL-6 production is mediated by the type 1 IL-1 receptor and is increased by 1,25 dihydroxyvitamin D3.Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype.17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism.Interleukin-11: a new cytokine critical for osteoclast developmentInterleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivoRegulation of bone cell development and function: implication for renal osteodystrophy.Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.The biochemical origin of pain--proposing a new law of pain: the origin of all pain is inflammation and the inflammatory response. Part 1 of 3--a unifying law of painEmerging strategies and therapies for treatment of Paget's disease of bone.The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part IIIMechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans.Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of boneGenome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone.Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorptionFibrous dysplasia of bone: the bone lesion unmasked.Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrowCHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclastsExpression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation.Paget disease of bone.Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and ManagementAntisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease.Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorptionMeasles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling.Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's diseaseExperimental models of Paget's disease.Osteoclasts - the innate immune cells of the bone.Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.Interactions between immune and bone cells: new insights with many remaining questions.Class A Scavenger Receptor Exacerbates Osteoclastogenesis by an Interleukin-6-Mediated Mechanism through ERK and JNK Signaling Pathways.Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow.TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation.Dickkopf-1 as a potential therapeutic target in Paget's disease of bone.Diazepam effects on non-syndromic cleft lip with or without palate: epidemiological studies, clinical findings, genes and extracellular matrix.c-FMS inhibitors: a patent review.
P2860
Q24329243-F4635A01-6C5E-4F1B-9560-43836C3B26DFQ24701798-B30FE216-F816-46B2-97F7-E3A59C8C65E1Q33204318-052DDBC1-642D-40F1-B497-585942BEC408Q33597248-E87C0DAE-ED01-4131-9C09-3A34D8C18CBCQ33896816-867C2B46-A90C-4C32-9A92-417DCD542E7DQ33939814-23180F72-79AA-4BBE-977A-F969467B52C2Q34130393-05B03A92-798B-411E-AD81-97ECE68067F8Q34138407-74EC0A1B-77C7-4889-972E-164B824FA285Q34224284-25CF6356-1F0A-4B88-94CE-C8A632B007D5Q34250588-386E34A3-80B8-402C-A007-49ACAD11F4BEQ34512953-30B1E5A5-1684-4A59-8AF7-44204CB86C42Q34604663-07A5D2F9-127F-4F67-95A9-A62DF383DB33Q34987305-F6CBE398-A51F-4A57-8CEE-76AE64B88F2FQ35116966-6AC8C031-7F5B-45C1-A240-CBA186E77D86Q35148782-E0B8AC8B-7B82-473E-B746-A58565B56CCDQ35180477-C7CF91AF-0464-4967-9849-AB3286210D44Q35416974-1D1DFC18-3944-4688-B547-CFA1A9479983Q35552797-F1144B4C-A5D8-4C3C-A12F-C9E80FEA9518Q35762562-088952F6-0E1F-48E2-A11C-1DB26F575B5AQ35764947-063A09D6-7586-4493-8E0B-52EF6D63F2BDQ35796423-223E71AD-9696-49C6-BBBB-A36F52906890Q35894360-0A0C67B4-7DF1-4A7F-A2F0-4D804495F1FAQ35986635-12CB958E-BA0C-4507-B46E-4A76069B8D07Q36029217-FBA85E29-596F-4AEC-A4C2-B3031AD52FBAQ36059397-39448945-56FA-4616-818A-C99CD7A932F6Q36169814-43A72FFB-A6A3-4A9F-A3AE-1A26C279BEBCQ36290634-7EAE7A8E-ED0F-463E-B4CC-CFE787EC24D0Q36553375-60F09DFD-856C-45B1-AF04-1D83CAFA7B84Q36618526-63F93EF1-E3FD-4852-BB62-1821F6424A6AQ36710199-78DC3BD8-525F-42D9-8EEC-BA50B3461CA4Q37118763-C1A5B8E1-A724-4358-BFF2-42E3A0091BFCQ37202226-AED0C740-23B4-4C61-9218-EEFD549F6020Q37270187-8C09D709-582D-4DF1-A9A0-0459335E53A3Q37348691-B835CEEF-F847-43E4-B6A7-94898A424EBAQ37356875-0DA635F8-E434-4179-910F-614E28C05AABQ37373492-957527EB-AA00-4C71-A729-D4FF85ABE5BFQ37407944-39E3B41B-3E67-4989-8764-84FEF3BC95DDQ37670256-B8F61039-5FD4-4617-AEFE-5096484BB701Q37774347-627CF545-A9AD-42A8-A828-7EEA25568732Q37825896-ED8202F6-5FE8-49B5-9527-D70A5003CD41
P2860
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone
@ast
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone
@en
type
label
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone
@ast
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone
@en
prefLabel
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone
@ast
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone
@en
P2093
P2860
P356
P1476
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone
@en
P2093
A Demulder
F R Singer
G D Roodman
N Kurihara
P2860
P356
10.1172/JCI115584
P407
P577
1992-01-01T00:00:00Z